Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Meta-analysis of association of rare mutations and common sequence variants in the MSR1 gene and prostate cancer risk.

Sun J, Hsu FC, Turner AR, Zheng SL, Chang BL, Liu W, Isaacs WB, Xu J.

Prostate. 2006 May 15;66(7):728-37.

PMID:
16425212
2.

Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancer.

Lindmark F, Jonsson BA, Bergh A, Stattin P, Zheng SL, Meyers DA, Xu J, Grönberg H.

Prostate. 2004 May 1;59(2):132-40.

PMID:
15042613
3.

Germ-line alterations in MSR1 gene and prostate cancer risk.

Seppälä EH, Ikonen T, Autio V, Rökman A, Mononen N, Matikainen MP, Tammela TL, Schleutker J.

Clin Cancer Res. 2003 Nov 1;9(14):5252-6.

4.

Germline mutations of the MSR1 gene in prostate cancer families from Germany.

Maier C, Vesovic Z, Bachmann N, Herkommer K, Braun AK, Surowy HM, Assum G, Paiss T, Vogel W.

Hum Mutat. 2006 Jan;27(1):98-102.

PMID:
16287155
5.

Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.

Rennert H, Zeigler-Johnson CM, Addya K, Finley MJ, Walker AH, Spangler E, Leonard DG, Wein A, Malkowicz SB, Rebbeck TR.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):949-57.

6.

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.

Xu J, Zheng SL, Komiya A, Mychaleckyj JC, Isaacs SD, Hu JJ, Sterling D, Lange EM, Hawkins GA, Turner A, Ewing CM, Faith DA, Johnson JR, Suzuki H, Bujnovszky P, Wiley KE, DeMarzo AM, Bova GS, Chang B, Hall MC, McCullough DL, Partin AW, Kassabian VS, Carpten JD, Bailey-Wilson JE, Trent JM, Ohar J, Bleecker ER, Walsh PC, Isaacs WB, Meyers DA.

Nat Genet. 2002 Oct;32(2):321-5. Epub 2002 Sep 16.

PMID:
12244320
7.

MSR1 variants and the risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.

Hsing AW, Sakoda LC, Chen J, Chokkalingam AP, Sesterhenn I, Gao YT, Xu J, Zheng SL.

Carcinogenesis. 2007 Dec;28(12):2530-6. Epub 2007 Sep 3.

PMID:
17768178
8.

Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men.

Miller DC, Zheng SL, Dunn RL, Sarma AV, Montie JE, Lange EM, Meyers DA, Xu J, Cooney KA.

Cancer Res. 2003 Jul 1;63(13):3486-9.

9.

Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer.

Hope Q, Bullock S, Evans C, Meitz J, Hamel N, Edwards SM, Severi G, Dearnaley D, Jhavar S, Southgate C, Falconer A, Dowe A, Muir K, Houlston RS, Engert JC, Roquis D, Sinnett D, Simard J, Heimdal K, Møller P, Maehle L, Badzioch M, Eeles RA, Easton DF, English DR, Southey MC, Hopper JL, Foulkes WD, Giles GG; Cancer Research UK/British Association of Urological Surgeons' Section of Oncology Collaborators.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):397-402.

10.

No association of germline alteration of MSR1 with prostate cancer risk.

Wang L, McDonnell SK, Cunningham JM, Hebbring S, Jacobsen SJ, Cerhan JR, Slager SL, Blute ML, Schaid DJ, Thibodeau SN.

Nat Genet. 2003 Oct;35(2):128-9. Epub 2003 Sep 7.

PMID:
12958598
11.

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness.

Casey G, Neville PJ, Liu X, Plummer SJ, Cicek MS, Krumroy LM, Curran AP, McGreevy MR, Catalona WJ, Klein EA, Witte JS.

Hum Mol Genet. 2006 Mar 1;15(5):735-41. Epub 2006 Jan 24.

PMID:
16434482
12.

Replication of prostate cancer risk loci in a Japanese case-control association study.

Yamada H, Penney KL, Takahashi H, Katoh T, Yamano Y, Yamakado M, Kimura T, Kuruma H, Kamata Y, Egawa S, Freedman ML.

J Natl Cancer Inst. 2009 Oct 7;101(19):1330-6. doi: 10.1093/jnci/djp287. Epub 2009 Sep 2.

PMID:
19726753
13.

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.

Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, Robbins C, Isaacs SD, Cheng Y, Li G, Sun J, Chang BL, Marovich L, Wiley KE, Bälter K, Stattin P, Adami HO, Gielzak M, Yan G, Sauvageot J, Liu W, Kim JW, Bleecker ER, Meyers DA, Trock BJ, Partin AW, Walsh PC, Isaacs WB, Grönberg H, Xu J, Carpten JD.

J Natl Cancer Inst. 2007 Dec 19;99(24):1836-44. Epub 2007 Dec 11.

PMID:
18073375
14.

Germline ATBF1 mutations and prostate cancer risk.

Xu J, Sauvageot J, Ewing CM, Sun J, Liu W, Isaacs SD, Wiley KE, Diaz L, Zheng SL, Walsh PC, Isaacs WB.

Prostate. 2006 Jul 1;66(10):1082-5.

PMID:
16637072
15.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

PMID:
17925536
16.

Association of testis derived transcript gene variants and prostate cancer risk.

Liu X, Cicek MS, Plummer SJ, Jorgenson E, Casey G, Witte JS.

J Urol. 2007 Mar;177(3):894-8.

PMID:
17296370
17.

The P275A Polymorphism in the Macrophage Scavenger Receptor 1 Gene and Prostate Cancer Risk: a Meta-Analysis.

Zhou QX, Tang JQ, Zhao F, Wei FL, Huang Y.

Asian Pac J Cancer Prev. 2015;16(13):5407-13.

18.

Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.

Nupponen NN, Wallén MJ, Ponciano D, Robbins CM, Tammela TL, Vessella RL, Carpten JD, Visakorpi T.

Genes Chromosomes Cancer. 2004 Feb;39(2):119-25.

PMID:
14695991
19.

Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.

Sun J, Lange EM, Isaacs SD, Liu W, Wiley KE, Lange L, Gronberg H, Duggan D, Carpten JD, Walsh PC, Xu J, Chang BL, Isaacs WB, Zheng SL.

Prostate. 2008 Apr 1;68(5):489-97. doi: 10.1002/pros.20695.

PMID:
18213635
20.

Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.

Hebbring SJ, Fredriksson H, White KA, Maier C, Ewing C, McDonnell SK, Jacobsen SJ, Cerhan J, Schaid DJ, Ikonen T, Autio V, Tammela TL, Herkommer K, Paiss T, Vogel W, Gielzak M, Sauvageot J, Schleutker J, Cooney KA, Isaacs W, Thibodeau SN.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):935-8.

Supplemental Content

Support Center